Journal
INFLAMMATION
Volume 36, Issue 1, Pages 42-52Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-012-9518-6
Keywords
retinal microglia; photoreceptor; inflammation; naloxone; proinflammatory factor
Categories
Funding
- National Natural Science Foundation for the Young Scholars of China [30901641]
- Shanghai Rising-Star Program [10QA1401200]
- Young Talents Program of Shanghai Health System [XYQ2011058]
- National Natural Science Foundation [81170857/H1205]
Ask authors/readers for more resources
Microglia-associated inflammation is closely related to the pathogenesis of retinal degenerative disorders. We have previously shown in vivo that naloxone protected photoreceptors from light-induced apoptosis possibly through inhibiting microglial activation. In this study, we attempted to explore the effect of lipopolysaccharide (LPS)-activated microglia on photoreceptor death and the influence of naloxone treatment using an in vitro retinal microglia and 661 W photoreceptor co-culture system. Immunofluorescent staining and ELISA measurements demonstrated that LPS activated microglia by changing the morphology and increasing the production of proinflammatory factors interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha. Flow cytometry analysis of annexin V/propidium iodide staining showed that LPS-activated microglia promoted the apoptosis of co-cultured 661 W photoreceptor cells. Naloxone inhibited microglial activation and decreased the release of IL-1beta and TNF-alpha but could not prevent photoreceptors from undergoing apoptosis. Considering the dual role of microglia-associated inflammation in both neurotoxicity and neuroprotection, modulating the function, rather than simply inhibiting their activation, might be a new therapeutic method for preventing photoreceptor degeneration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available